Taken together, these data suggest that a decreased Beclin 1 expression occurs frequently in tumors when compared to normal samples, and it also suggest that lower Beclin 1 levels usually correlate with a worse prognosis in multiple cancer types. Here, BECN1 is linked to cancer.